Type 2 Diabetes Mellitus Clinical Trials in Kansas City, Missouri

5 studies are recruiting for type 2 diabetes mellitus in Kansas City, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

    The purpose of this study is to assess the efficacy and safety of enicepatide, a dual glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist (RA), at multiple doses compared with placebo for weight management in participants with obesity or overweight an…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Kansas City VA Medical Center, Kansas City, Missouri
    Locations
    204 in total
    Run by
    Hoffmann-La Roche

    See if you can join NCT07351058 on ClinicalTrials.gov

  2. A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

    The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM and increased cardiovascular risk that is inadequately managed alone or on stable treatment with other background glucose-lowering medication(s).

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Research Site, Kansas City, Missouri
    Locations
    209 in total
    Run by
    AstraZeneca

    See if you can join NCT07662213 on ClinicalTrials.gov

  3. A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

    The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron, compared with placebo in adults with type 2 diabetes mellitus (T2DM) and impaired renal function, who are or will be on a background of sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin 10…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Research Site, Kansas City, Missouri
    Locations
    186 in total
    Run by
    AstraZeneca

    See if you can join NCT07662135 on ClinicalTrials.gov

  4. A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

    The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron alone or in combination with dapagliflozin compared with placebo in adults with type 2 diabetes mellitus (T2DM) inadequately managed with lifestyle management alone or treated with other background gluco…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Research Site, Kansas City, Missouri
    Locations
    149 in total
    Run by
    AstraZeneca

    See if you can join NCT07662044 on ClinicalTrials.gov

  5. Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

    This study is a Phase 2 clinical trial to evaluate the efficacy, safety, and tolerability of HM15275 in subjects with type 2 diabetes mellitus over 36 weeks.

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Clay Platte Family Medicine, Kansas City, Missouri
    Locations
    15 in total
    Run by
    Hanmi Pharmaceutical Company Limited

    See if you can join NCT07527650 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.